What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Blood pressure
His primary areas of study are Internal medicine, Blood pressure, Cardiology, Surgery and Genome-wide association study.
The concepts of his Internal medicine study are interwoven with issues in Placebo and Endocrinology.
His Blood pressure research includes themes of Kidney and Disease.
His work on Heart failure as part of general Cardiology research is frequently linked to Evolocumab, thereby connecting diverse disciplines of science.
His Surgery research is multidisciplinary, incorporating perspectives in Urine, Atorvastatin, Epidemiology and Risk factor.
His study in Genome-wide association study is interdisciplinary in nature, drawing from both Genetic association, Bioinformatics and Medical genetics.
His most cited work include:
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial (3235 citations)
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial (2328 citations)
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (2219 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Blood pressure, Endocrinology, Cardiology and Surgery.
Internal medicine and Placebo are frequently intertwined in his study.
His Blood pressure study combines topics from a wide range of disciplines, such as Hemodynamics and Anesthesia.
His Cardiology study integrates concerns from other disciplines, such as Left ventricular hypertrophy and PCSK9.
The study incorporates disciplines such as Hazard ratio, Disease and Risk factor in addition to Surgery.
In his work, Regimen and Perindopril is strongly intertwined with Atenolol, which is a subfield of Amlodipine.
He most often published in these fields:
- Internal medicine (59.18%)
- Blood pressure (28.16%)
- Endocrinology (23.88%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (59.18%)
- Evolocumab (7.35%)
- PCSK9 (6.12%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Evolocumab, PCSK9, Blood pressure and Cardiology.
His work on Placebo expands to the thematically related Internal medicine.
Peter S. Sever has researched Placebo in several fields, including Interquartile range, Clinical trial, Adverse effect and Hazard ratio.
His PCSK9 research incorporates elements of Statin, Ezetimibe, Proprotein convertase and Unstable angina.
His Statin research is multidisciplinary, incorporating elements of Rosuvastatin and Atorvastatin.
His research in Blood pressure intersects with topics in Genetics, Genome-wide association study and Heart failure.
Between 2016 and 2021, his most popular works were:
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (2219 citations)
- Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries (799 citations)
- Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. (284 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Blood pressure
His primary areas of investigation include Internal medicine, PCSK9, Evolocumab, Genome-wide association study and Blood pressure.
His studies in Internal medicine integrate themes in fields like Placebo and Cardiology.
His PCSK9 research is multidisciplinary, relying on both Proprotein convertase, Lipoprotein and Ezetimibe.
Evolocumab is intertwined with Clinical endpoint and Surgery in his study.
His Genome-wide association study study combines topics in areas such as Disease, Genetic association, Bioinformatics and Medical genetics.
His Blood pressure research focuses on Gene and how it relates to Kidney.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
